Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke

Ischemic and hemorrhagic strokes are associated with severe functional disability and high mortality. Except for recombinant tissue plasminogen activator, therapies targeting the underlying pathophysiology of central nervous system (CNS) ischemia and hemorrhage are strikingly lacking. Sur1-regulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Caffes, Nicholas, Kurland, David B., Gerzanich, Volodymyr, Simard, J. Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394459/
https://www.ncbi.nlm.nih.gov/pubmed/25749474
http://dx.doi.org/10.3390/ijms16034973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394459/
https://www.ncbi.nlm.nih.gov/pubmed/25749474
http://dx.doi.org/10.3390/ijms16034973

Ejemplares similares